BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26342928)

  • 1. Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.
    Norman R; Viney R; Aaronson NK; Brazier JE; Cella D; Costa DS; Fayers PM; Kemmler G; Peacock S; Pickard AS; Rowen D; Street DJ; Velikova G; Young TA; King MT
    Qual Life Res; 2016 Mar; 25(3):637-49. PubMed ID: 26342928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.
    King MT; Viney R; Simon Pickard A; Rowen D; Aaronson NK; Brazier JE; Cella D; Costa DSJ; Fayers PM; Kemmler G; McTaggart-Cowen H; Mercieca-Bebber R; Peacock S; Street DJ; Young TA; Norman R;
    Pharmacoeconomics; 2018 Feb; 36(2):225-238. PubMed ID: 29270835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.
    Shiroiwa T; King MT; Norman R; Müller F; Campbell R; Kemmler G; Murata T; Shimozuma K; Fukuda T
    Qual Life Res; 2024 Jul; 33(7):1865-1879. PubMed ID: 38724771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EORTC QLU-C10D: the Hong Kong valuation study.
    Xu RH; Wong EL; Luo N; Norman R; Lehmann J; Holzner B; King MT; Kemmler G;
    Eur J Health Econ; 2023 Sep; ():. PubMed ID: 37768519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danish value sets for the EORTC QLU-C10D utility instrument.
    Lehmann J; Rojas-Concha L; Petersen MA; Holzner B; Norman R; King MT; Kemmler G;
    Qual Life Res; 2024 Mar; 33(3):831-841. PubMed ID: 38183563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment.
    Finch AP; Gamper E; Norman R; Viney R; Holzner B; King M; Kemmler G;
    Pharmacoeconomics; 2021 Sep; 39(9):1085-1098. PubMed ID: 34216380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
    Pilz MJ; Seyringer S; Al-Naesan I; King MT; Bottomley A; Norman R; Schlosser L; Hell T; Gamper EM;
    Pharmacoecon Open; 2024 May; ():. PubMed ID: 38696019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Preferences and Data Quality between Discrete Choice Experiments Conducted in Online and Face-to-Face Respondents.
    Jiang R; Pullenayegum E; Shaw JW; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
    Med Decis Making; 2023 Aug; 43(6):667-679. PubMed ID: 37199407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation.
    Xie S; Wu J; Xie F
    Value Health; 2023 Sep; 26(9):1405-1412. PubMed ID: 37285916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
    Pilz MJ; Seyringer S; Hallsson LR; Bottomley A; Jansen F; King MT; Norman R; Rutten MJ; Leeuw IMV; Siersema PD; Gamper EM
    Eur J Health Econ; 2024 Mar; ():. PubMed ID: 38483665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health utility assessments in individuals undergoing diagnostic and surveillance colonoscopy: improved discrimination with a cancer-specific scale.
    Bulamu NB; Chen G; McGrane E; Cock C; Young GP; Symonds EL
    Cancer Causes Control; 2024 Feb; 35(2):347-357. PubMed ID: 37747615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.
    King MT; Revicki DA; Norman R; Müller F; Viney RC; Pickard AS; Cella D; Shaw JW;
    Pharmacoecon Open; 2024 Jan; 8(1):49-63. PubMed ID: 38060096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four value sets derived using different TTO and DCE approaches: application to the new region-specific PBM, AP-7D.
    Shiroiwa T; Murata T; Morii Y; Hoshino E; Fukuda T
    Health Qual Life Outcomes; 2024 Feb; 22(1):16. PubMed ID: 38341575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.
    Daroudi R; Zeraati H; Poder TG; Norman R; Olyaeemanesh A; Sari AA; Ameri H
    Qual Life Res; 2024 Jul; 33(7):1853-1863. PubMed ID: 38630166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment.
    Hettiarachchi RM; Arrow P; Senanayake S; Carter H; Brain D; Norman R; Tonmukayawul U; Jamieson L; Kularatna S
    Eur J Health Econ; 2023 Nov; 24(8):1285-1296. PubMed ID: 36394684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing the Dental Caries Utility Index in Australia.
    Hettiarachchi RM; Kularatna S; Byrnes J; Mulhern B; Chen G; Scuffham PA
    Med Decis Making; 2023; 43(7-8):901-913. PubMed ID: 37724663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating a Preference-Based Value Set for the Mental Health Quality of Life Questionnaire (MHQoL).
    van Krugten FCW; Jonker MF; Himmler SFW; Hakkaart-van Roijen L; Brouwer WBF
    Med Decis Making; 2024 Jan; 44(1):64-75. PubMed ID: 37981788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valuing Chinese medicine quality of life-11 dimensions (CQ-11D) health states using a discrete choice experiment with survival duration (DCE
    Zhu W; Zhang M; Pan J; Shi L; Gao H; Xie S
    Health Qual Life Outcomes; 2023 Aug; 21(1):99. PubMed ID: 37612664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.
    Smith AB; Hanbury A; Whitty JA; Buesch K
    Patient Relat Outcome Meas; 2021; 12():97-106. PubMed ID: 34012310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public preferences regarding data linkage for research: a discrete choice experiment comparing Scotland and Sweden.
    Tully MP; Bernsten C; Aitken M; Vass C
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):109. PubMed ID: 32546147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.